Related content

Further evidence for the association between 5-HT_2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients

By Gunes Arzu   Dahl Marja-Liisa   Spina Edoardo   Scordo Maria  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 5, 2008-05 ,pp. : 477-482

Springer Publishing Company

Access to resources Recommend Favorite

Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms

By Güzey Cüneyt   Scordo Maria   Spina Edoardo   Landsem Veslemøy   Spigset Olav  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 3, 2007-03 ,pp. : 233-241

Springer Publishing Company

Access to resources Recommend Favorite

genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients

By Scordo M.G.   Spina E.   Romeo P.   Dahl M.-L.   Bertilsson L.   Johansson I.   Sjöqvist F.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 679-683

Springer Publishing Company

Access to resources Recommend Favorite

The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: An open label study

By Dorfman-Etrog P.   Hermesh H.   Prilipko L.   Weizman A.   Munitz H.  

European Neuropsychopharmacology, Vol. 9, Iss. 6, 1999-12 ,pp. : 475-477

Elsevier

Access to resources Recommend Favorite

Occupancy of dopamine D₁, D₂ and serotonin_2A receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol

By Reimold M.   Solbach C.   Noda S.   Schaefer J.-E.   Bartels M.   Beneke M.   Machulla H.-J.   Bares R.   Glaser T.   Wormstall H.  

Psychopharmacology, Vol. 190, Iss. 2, 2007-02 ,pp. : 241-249

Springer Publishing Company

Access to resources Recommend Favorite